US Stock MarketDetailed Quotes
TAK Takeda Pharmaceutical
- 13.030
- -0.040-0.31%
Close Apr 26 16:00 ET
- 13.540
- +0.510+3.91%
Post 19:56 ET
41.24BMarket Cap36.30P/E (TTM)
13.080High13.005Low1.21MVolume13.080Open13.070Pre Close15.81MTurnover0.04%Turnover Ratio20.08P/E (Static)3.16BShares16.77352wk High0.95P/B39.96BFloat Cap13.00552wk Low0.63Dividend TTM3.07BShs Float20.779Historical High4.84%Div YieldTTM0.57%Amplitude11.808Historical Low13.030Avg Price1Lot Size
Takeda Pharmaceutical Key Stats
Quarterly+Annual
YOY
| (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | (FY)Mar 31, 2022 | (Q4)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -61.28%146.45B | -9.99%198.91B | 9.68%92.4B | -13.00%977.16B | -21.80%293.69B | 8.84%378.23B | -5.22%220.99B | -49.51%84.24B | 11.10%1.12T | -6.33%375.59B |
| Net income from continuing operations | -11.24%105.76B | -177.71%-47.97B | -14.87%89.41B | 37.74%317.04B | 373.71%31.14B | 106.07%119.15B | 34.21%61.73B | -23.75%105.02B | -38.81%230.17B | -105.77%-11.38B |
| Operating gains losses | -63.84%413M | -419.36%-2.19B | 224.46%597M | -77.63%1.83B | -104.77%-180M | -18.66%1.14B | -76.54%687M | 113.95%184M | 103.53%8.19B | 101.90%3.78B |
| Depreciation and amortization | 5.76%187.06B | 8.86%182.7B | 8.35%171.5B | 13.93%664.4B | 6.00%161.41B | 20.10%176.88B | 19.32%167.83B | 10.73%158.28B | 4.20%583.15B | 9.24%152.27B |
| Deferred tax | -270.92%-44.5B | -1,804.26%-48.01B | -9.56%45.63B | -19.82%58.05B | 139.32%16.78B | -183.46%-12B | -81.77%2.82B | -40.82%50.45B | 828.71%72.41B | 35.60%-42.67B |
| Other non cash items | 0.98%71.91B | -38.99%41.93B | 26.62%-34.52B | -90.23%18.01B | -188.54%-74.89B | 19.57%71.21B | 36.91%68.72B | -369.56%-47.04B | 52.68%184.31B | 9.35%84.58B |
| Change In working capital | -423.60%-166.02B | 105.05%1.59B | 19.91%-150.95B | -125.62%-25.26B | -19.75%143.39B | -28.36%51.3B | -441.81%-31.49B | -17.13%-188.47B | -64.25%98.61B | -22.96%178.68B |
| -Change in receivables | 11.88%14.29B | 43.44%17.29B | -402.91%-90.37B | -40.98%75.13B | 51.54%68.27B | -90.71%12.77B | 190.27%12.06B | 57.05%-17.97B | 1,466.40%127.29B | 10.98%45.05B |
| -Change in inventory | -173.82%-50.55B | -640.98%-49.35B | -213.54%-28.59B | -71.52%-79.16B | -552.83%-44.92B | -29.08%-18.46B | -68.35%-6.66B | 56.60%-9.12B | -277.64%-46.15B | -134.54%-6.88B |
| -Change in payables and accrued expense | 1,011.24%70.27B | 62.57%-15.02B | 64.32%-34.66B | -167.76%-84.8B | -52.61%60.17B | -206.42%-7.71B | -353.85%-40.14B | -290.77%-97.12B | 241.77%125.16B | 204.43%126.95B |
| -Change in other current liabilities | -210.03%-44.19B | 327.89%8.92B | 157.20%25.25B | 163.84%31.67B | 2,453.23%39.58B | 176.97%40.16B | -143.47%-3.92B | -452.94%-44.15B | -128.61%-49.61B | -98.95%1.55B |
| -Change in other working capital | -734.91%-155.83B | 454.57%39.75B | -12.32%-22.58B | 154.91%31.9B | 69.00%20.29B | 472.67%24.54B | 320.35%7.17B | 69.17%-20.11B | -218.31%-58.09B | 167.67%12.01B |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -61.28%146.45B | -9.99%198.91B | 9.69%92.4B | -13.00%977.16B | -21.80%293.69B | 8.84%378.23B | -5.22%220.99B | -49.51%84.24B | 11.10%1.12T | -6.33%375.58B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -61.20%-75.27B | -122.66%-60.58B | -181.41%-266.53B | -206.42%-607.1B | -1,610.32%-438.49B | 32.47%-46.69B | 17.31%-27.21B | -34.45%-94.71B | -150.35%-198.13B | -108.74%-25.64B |
| Net PPE purchase and sale | -39.82%-46.81B | -0.98%-29.52B | -9.16%-45.95B | -15.03%-139.7B | -2.08%-34.89B | -23.78%-33.48B | 4.00%-29.24B | -41.44%-42.09B | -87.54%-121.44B | -5.06%-34.18B |
| Net intangibles purchase and sale | -75.09%-30.04B | -184.64%-32.2B | -296.94%-223.28B | -685.27%-493.03B | -2,413.61%-408.31B | 19.66%-17.16B | 11.13%-11.31B | -351.67%-56.25B | 49.88%-62.79B | 78.57%-16.24B |
| Net business purchase and sale | --0 | ---7M | --372M | 137.06%7.96B | -69.46%7.96B | --0 | --0 | --0 | -104.05%-21.48B | -93.57%26.06B |
| Net investment purchase and sale | -242.39%-2B | -114.36%-1.5B | -104.04%-131M | 41.06%12.1B | -2,716.52%-3.01B | -29.20%1.41B | 13.13%10.46B | 217.23%3.25B | -86.16%8.58B | 105.16%115M |
| Net other investing changes | -83.85%63M | 65.36%-133M | 93.78%-14M | 58.35%-3.05B | -7.11%-2.83B | 111.50%390M | 48.80%-384M | 58.41%-225M | 29.16%-7.33B | -28.40%-2.65B |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -61.21%-75.27B | -122.67%-60.58B | -181.41%-266.53B | -206.42%-607.1B | -1,610.32%-438.49B | 32.47%-46.69B | 17.32%-27.21B | -34.45%-94.71B | -150.35%-198.13B | -108.74%-25.64B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 77.52%-97.76B | -171.14%-140.65B | 73.22%-57.78B | 33.74%-709.15B | 97.29%-6.6B | -158.81%-434.96B | 79.03%-51.88B | 47.52%-215.72B | 1.66%-1.07T | 34.12%-243.8B |
| Net issuance payments of debt | 127.61%73.49B | -1,358.81%-157.07B | 367.62%99.37B | 52.53%-285.07B | 115.70%29.02B | -678.82%-266.2B | 94.83%-10.77B | 85.34%-37.13B | 9.09%-600.48B | 45.34%-184.86B |
| Net common stock issuance | --0 | --0 | 91.36%-2.33B | 65.27%-26.93B | --0 | --0 | --0 | -959.36%-26.93B | -3,521.25%-77.53B | -833,000.00%-24.99B |
| Cash dividends paid | -7.18%-138.25B | 18.58%-9.07B | -1.45%-130.75B | 1.50%-279.42B | 2.09%-10.42B | 1.87%-128.99B | -16.70%-11.13B | 2.39%-128.87B | -0.11%-283.67B | -22.62%-10.64B |
| Net other financing activities | 31.98%-4.03B | 213,084.62%55.38B | -26,506.25%-4.26B | -2,283.64%-9.18B | -17,750.00%-3.21B | -1,572.88%-5.92B | ---26M | ---16M | 98.90%-385M | -12.50%-18M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 77.52%-97.76B | -171.14%-140.66B | 73.22%-57.78B | 33.74%-709.15B | 97.29%-6.6B | -158.81%-434.96B | 79.03%-51.88B | 47.52%-215.72B | 1.66%-1.07T | 34.12%-243.8B |
| Net cash flow | ||||||||||
| Beginning cash position | -60.15%318.05B | -51.02%316.38B | -37.21%533.53B | -12.06%849.7B | -5.41%685.14B | 31.30%798.14B | -1.36%645.99B | -12.06%849.7B | 51.54%966.22B | 17.28%724.34B |
| Current changes in cash | 74.30%-26.58B | -101.64%-2.33B | -2.53%-231.91B | -133.40%-339.09B | -242.63%-151.4B | -193.75%-103.42B | 401.19%141.91B | 28.11%-226.19B | -145.96%-145.29B | -67.27%106.15B |
| Effect of exchange rate changes | 67.48%-3.12B | -60.92%4B | -34.36%14.76B | -20.27%22.93B | -101.10%-212M | -255.83%-9.58B | 13,021.79%10.24B | 576.44%22.49B | 130.05%28.76B | -20.94%19.21B |
| End cash Position | -57.91%288.36B | -60.15%318.05B | -51.02%316.38B | -37.21%533.53B | -37.21%533.53B | -5.41%685.14B | 31.30%798.14B | -1.36%645.99B | -12.06%849.7B | -12.06%849.7B |
| Free cash flow | -78.84%69.33B | -28.56%128.86B | -1,151.06%-176.84B | -63.35%343.47B | -146.45%-150.39B | 9.54%327.61B | -4.89%180.38B | -111.35%-14.14B | 21.00%937.07B | 12.03%323.76B |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg